Shu Peng
- Oncology
- Infectious Diseases top 10%
- Pulmonary and Respiratory Medicine
- Neurology
- Clinical Psychology
- Co-authors
- Xiangning FuNi ZhangPing WeiYangkai LiLequn LiQi WangBo ZhaoLiu Huang
- Topics
- COVID-19 and healthcare impacts (4 papers)COVID-19 Clinical Research Studies (3 papers)COVID-19 diagnosis using AI (3 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Shu Peng
8 papers receiving 272 citations
Peers
Comparison fields: 5 of 58
- Oncology 145
- Infectious Diseases 143
- Pulmonary and Respiratory Medicine 105
- Neurology 63
- Clinical Psychology 33
Countries citing papers authored by Shu Peng
This map shows the geographic impact of Shu Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Peng more than expected).
Fields of papers citing papers by Shu Peng
This network shows the impact of papers produced by Shu Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Peng. The network helps show where Shu Peng may publish in the future.
Co-authorship network of co-authors of Shu Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Shu Peng. A scholar is included among the top collaborators of Shu Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Peng. Shu Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 42 | |
| 6 | 74 | |
| 7 | 150 | |
| 8 | 1 |
About Shu Peng
Shu Peng is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 8 papers that have together received 278 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (4 papers), COVID-19 Clinical Research Studies (3 papers) and COVID-19 diagnosis using AI (3 papers). The work is most often cited by research in Infectious Diseases (143 citations), Critical Care and Intensive Care Medicine (32 citations) and Oncology (145 citations). Shu Peng has collaborated with scholars based in China, United States and India. Frequent co-authors include Xiangning Fu, Ni Zhang, Ping Wei, Yangkai Li, Lequn Li, Qi Wang, Bo Zhao, Liu Huang, Qian Chu and Shuchang Zhou. Their work appears in journals such as Journal of Thoracic and Cardiovascular Surgery, Current Medicinal Chemistry and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.